Key Insights

Highlights

Success Rate

50% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 77/100

Termination Rate

50.0%

2 terminated out of 4 trials

Success Rate

50.0%

-36.5% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results50% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
P 1 (1)
P 3 (1)

Trial Status

Terminated2
Completed2

Trial Success Rate

50.0%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT04534075Phase 3Completed

Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial

NCT04964297Not ApplicableTerminated

Evaluation of Ability to Detect Bowel Gas During Laparoscopic Right Colectomy With Intracorporeal Anastomosis

NCT04975256Phase 1Terminated

Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)

NCT02378337Completed

Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality

Showing all 4 trials

Research Network

Activity Timeline